Postmenopausal Estrogens and Breast Cancer

Abstract

References

1. King, M-C . Rowell S , Love SM . Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 1993, 269:1975-1980.

2. Colditz, GA , Willett WC , Hunter DJ , et al. Family history, age and risk of breast cancer: Prospective data from the Nurses' Health Study. JAMA 1993;270:338-343.

3. Tokunaga M , Land CE , Yamamoto T , Asano M , Tokuoka S , Ezaka, H , Nishimori I . Incident of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res 1987;112:243-272.

4. Tokunaga M , Land CE , Tokuoka S , Nishimori I , Soda M , Akiba S . Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 1994;138:209-223.

5. London SJ , Connolly JL , Schnitt SJ , Colditz, GA . A prospective study of benign breast disease and risk of breast cancer. JAMA 1992;267:941-944.

6. Colditz GA , Willett WC . Epidemiology of breast cancer: Implications for primary prevention. In: Harris JR , ed. Breast disease updates, Philadelphia: JB Lippincott Company, 1992:1-17.

7. Stemberg KK , Thacker SB , Smith SJ , Zack MM , Flanders WD , Berkelman RL . A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-1990.

8. Sillero-Arenas M , Delgado-Rodriguez M , Rodrigues-Canteras R , Bueno-Cavanillas A , Galvez-Vargus R , Menopausal hormone replacement therapy and breast cancer: A meta-analysis, Obstet Gynecol 1992;79:286-294.

9. Colditz GA , Egan KM , Stampfer MJ . Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies. Am J Obstet Gyn 1993;168:1473-1480.

10.

10. Steinberg KK , Smith SJ , Thacker SB , Stroup DF . Breast cancer risk and duration of estrogen use: The role of study design in meta-analysis. Epidemiology 1994;5:415-421.

11.

11. Newcomb PA , Longnecker MP , Storer BE , et al. Long-term hormone replacement therapy and risk of breast cancer in post-menopausal women. Am J Epidemiol 1995;142:788-795.

12.

12. Stanford JL , Weiss NS , Voigt LF , Daling JR , Habel LA , Rossing MA . Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995;274:137-142.

13.

13. Schuurman AG , van den Brandt PA , Goldbohm RA . Exogenous hormone use and the risk of postmonepausal breast cancer: Results fromthe Netherlands cohort study. Cancer Causes Control 1995;6:416-424.

14.

14. Key TJA , Pike MC . The role of estrogen and progestins in the epidemiology and prevention of breast cancer. Eur J Clin Oncol 1988;24:29-43.

15.

15. Pike MC , Krailo MD , Henderson BE , Casagrande JT , Hoel DG . “Hormonal” risk factors, “breast tissue age” and the age-incidence of breast cancer. Nature 1983;303:767-770.

16.

16. Rosner B , Colditz GA , Willett WC . Reproductive risk factors in a prospective study of breast cancer. The Nurses' Health Study. Am J Epidemiol 1994;139:819-835.

17.

17. Russo IH , Russo J . Physiologic bases of breast cancer prevention. Eur J Cancer Prevent 1993;2(suppl):101-111.

18.

18. Lambe M , Hsieh C-c , Trichopoulos D , Ekbom A , Pavia M , Adami H-O . Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331;5-9.

19.

19. Hsieh C , Pavia M , Lambe M , et al. Dual effect of parrity on breast cancer risk. Eur J Cancer 1994;30A:969-973.

20.

20. Gray GE , Henderson BE , Pike MC . Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst 1980;64:461-463.

21.

21. US Bureau of Census. Current population reports. Fertility of American women: June 1983. Population characteristics. Series P-20, no 395.

22.

22. US Bureau of Census. Op cit, table 13.

23.

23. van Weinngen JC . Secular growth changes. In Falkner F , Tanner JM , eds. Human growth: A comprehensive treatise. New York: Plenum Press, 1986:307-332.

24.

24. Chen J , Campbell TC , Junyao L , Peto R . Diet, lifestyle and mortality in China. Oxford, United Kingdom: Oxford University Press, 1999.

25.

25. Hunter DJ , Willett WC . Diet, body size and breast cancer. Epidemiol Rev 1993;15:110-132.

26.

26. Vatten LJ , Kvinnsland S . Prospective study of height, body mass index and risk of breast cancer. Acta Oncol 1992;31:195-200.

27.

27. Trichopoulos D , MacMahon B , Cole P . Menopause and breast cancer. J Nat Cancer Inst 1972;48:605-613.

28.

28. Gambrell RD Jr , Maier RC , Sanders BI . Decreased incidence of breast cancer in postmenopausal estrogen-progesterone users. Obstet Gynecol 1983;62:435-443.

29.

29. Jurgens RW Jr , Downey LJ , Abernathy WD , Cutler NR , Conrad J . A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy. Am J Obstet Gynecol 1992;167:459-460.

30.

30. Hankinson SE , Willett WC , Manson JE , et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87:1297-1302.

31.

31. Colditz GA , Stampfer MJ , Willett WC , et al. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1990;264:2648-2653.

32.

32. Palmer JR , Rosenberg L , Clarke EA , et al. Breast cancer risk after estrogen replacement therapy: Results from the Toronto Breast Cancer Study. Am J Epidemiol 1991;134:1385-1395.

33.

33. Brinton LA , Hoover R , Fraumeni JF . Menopausal oestrogens and breast cancer risk: An expanded case-control study. Br J Cancer 1986;54:825-832.

34.

34. Wingo PA , Layde PM , Lee NC , et al. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA 1987;257:209-215.

35.

35. Colditz GA , Hankinson SE , Hunter DJ , et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-1593.

36.

36. Gambrell RD . Hormones in the etiology and prevention of breast and endometrial cancer. South Med J 1984;77:1509-1515.

37.

37. Ewertz M . Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer 1988;42:832-838.

38.

38. Bergkvist L , Adami HO , Persson I , et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989;321:293-297.

39.

39. Colditz GA , Stampfer MJ , Willett WC , et al. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control 1992;3:433-439.

40.

40. Stanford JL , Thomas DB . Exogenous progestins and breast cancer. Epidemiol Rev 1993;15:98-107.

41.

41. Gambrell RD , Maier RC , Sanders BI . Decreased incidence of breast cancer in postmenopausal estrogen-progesterone users. Obstet Gynecol 1983;62:435-443.

42.

42. Kaufman DW , Palmer JR , Demouzon J , et al. Estrogen replacement therapy and risk of breast cancer: Results from case-control surveillance study. Am J Epidemiol 1991;134:1375-1385.

43.

43. Yang C , Daling JR , Bard PR . et al. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control 1992;3:475-479.

44.

44. Felson DT , Zhang Y , Hannan MT , et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-1146.

45.

45. Ettinger B , Grady D . The waning effect of postmenopausal estrogen therapy on osteoporosis (editorial). N Engl J Med 1993;329:1192-1193.

46.

46. Lees B , Molleson T , Arnett TR , Stevenson JC . Differences in proximal femur bone density over two centuries. Lancet 1993;341:673-675.

47.

47. Stampfer MJ , Colditz GA , Willett WC , et al. A prospective study of postmenopausal estrogen therapy and cardiovascular disease in women. N Engl J Med 1991;325:756-762.

48.

48. Stampfer MJ , Colditz GA . Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.